RO Roche Holding AG

SWX · CH · Healthcare · Drug Manufacturers - General · roche.com

357.20CHF+0.39%Mkt Cap: 325.55B $P/E: 23.351d ago

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas o…

Industry Peers

Drug Manufacturers - General

Screen all

LLY

Eli Lilly and Company Common Stock

$1.02TUSDP/E 38.4

JNJ

Johnson & Johnson Common Stock

$617.01BUSDP/E 29.7

ABBV

AbbVie Inc. Common Stock

$464.43BUSDP/E 74.2

MRK

Merck & Company, Inc. Common Stock (new)

$356.01BUSDP/E 116.4

NVS

Novartis AG Common Stock

AstraZeneca PLC Ordinary Shares

Amgen Inc. - Common Stock

Gilead Sciences, Inc. - Common Stock

$179.47BUSD

NVO

Novo Nordisk A/S Common Stock

$164.79BUSDP/E 9.4

PFE

Pfizer, Inc. Common Stock

$158.45BUSDP/E 36.6

BMY

Bristol-Myers Squibb Company Common Stock

$124.91BUSDP/E 13.5

SNY

Sanofi - American Depositary Shares

$95.65BUSDP/E 21.8

GSK

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Bayer Aktiengesellschaft

$46.94BUSD

Key Statistics

Company

Market Cap325.55B USD

Enterprise Value355.04B USD

Revenue (TTM)71.86B USD

Gross Profit53.31B USD

Net Income (TTM)14.70B USD

Revenue/Share79.09 CHF

Last Price357.20 CHF

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryCH

SectorHealthcare

IndustryDrug Manufacturers - General

ISINCH0012032048

Valuation

P/E (Trailing)23.35

P/E (Forward)16.17

PEG1.62

EV/EBITDA12.98

EV/Revenue4.94

P/S4.50

P/B8.67

EPS (TTM)15.33

EPS (Forward)22.01

52W Range

264.6078% of range383.00

52W High383.00 CHF

52W Low264.60 CHF

Profitability

Gross Margin73.73%

Oper. Margin36.20%

EBITDA Margin38.06%

Profit Margin20.33%

ROE38.10%

ROA12.79%

Growth

Revenue Growth-1.20%

Earnings Growth-7.70%

Cash Flow & Leverage

Operating CF21.52B USD

CapEx (TTM)6.60B USD

FCF Margin16.39%

FCF Yield3.62%

Net Debt26.91B USD

Net Debt/EBITDA0.98

Balance Sheet

Debt/Equity0.98

Current Ratio1.23

Quick Ratio0.80

Book Value/Sh41.03 CHF

Cash/Share12.22 CHF

Dividends

Fwd Div Rate9.80 CHF

Trail. Div Rate9.80 CHF

Div. Yield2.75%

5Y Avg Yield2.98%

Payout Ratio63.93%

Ex-Div DateMar 12, 2026

Pay DateMar 31, 2025

Splits

Last Split100:1

Split DateMay 4, 2001

Analyst Consensus

Rating—

Target (Mean)368.00 CHF

Upside (mean)+3.0%

Target Range340.00 CHF – 396.00 CHF

340.00+3.0% to mean396.00

# Analysts2

Ownership

Shares Out.106.69M

Float723.68M

Insiders72.31%

Institutions11.04%

Technical

SMA 50366.98 (-2.7%)

SMA 200347.18 (+2.9%)

Beta0.35

S&P 52W Chg14.58%

Avg Vol (30d)33.80K

Avg Vol (10d)30.83K

Technical Indicators

RSI (14)39.7

MACD-0.4122

MACD Signal1.2724

MACD Hist.-1.6846

BB Upper380.81 CHF

BB Middle365.01 CHF

BB Lower349.21 CHF

BB Width8.66%

ATR (14)7.815 CHF

Vol Ratio (20d)0.69x